Literature DB >> 15844384

Glomerulonephritis.

Keith K Lau1, Robert J Wyatt.   

Abstract

GN in the adolescent requires prompt diagnosis. When even mild degrees of renal insufficiency are documented, immediate referral to a nephrologist is necessary to ensure that serious conditions, such as RPGN, are correctly diagnosed and aggressively managed. In an adolescent with macroscopic hematuria, the demonstration of dysmorphic RBCs, RBC casts, and proteinuria indicates that the bleeding is of glomerular origin. Physicians caring for adolescents with chronic GN should have a basic understanding of the specific disorders. They may be involved in blood pressure monitoring and should be aware of the potential side effects of the antihypertensive and immunosuppressive medications used in patients with GN.

Entities:  

Mesh:

Year:  2005        PMID: 15844384     DOI: 10.1016/j.admecli.2004.09.008

Source DB:  PubMed          Journal:  Adolesc Med Clin        ISSN: 1041-3499


  4 in total

Review 1.  Bench-to-bedside review: pulmonary-renal syndromes--an update for the intensivist.

Authors:  Spyros A Papiris; Effrosyni D Manali; Ioannis Kalomenidis; Giorgios E Kapotsis; Anna Karakatsani; Charis Roussos
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

2.  Protracted Clinical Course of Postinfectious Glomerulonephritis in a Previously Healthy Child.

Authors:  Camilla Grøndahl; Søren Rittig; Johan Vestergaard Povlsen; Kostantinos Kamperis
Journal:  Case Rep Nephrol Dial       Date:  2016-04-14

Review 3.  Prospects for Precision Medicine in Glomerulonephritis Treatment.

Authors:  Yulu Cherry Liu; Justin Chun
Journal:  Can J Kidney Health Dis       Date:  2018-02-09

4.  Micelle-Forming Dexamethasone Prodrug Attenuates Nephritis in Lupus-Prone Mice without Apparent Glucocorticoid Side Effects.

Authors:  Zhenshan Jia; Xiaobei Wang; Xin Wei; Gang Zhao; Kirk W Foster; Fang Qiu; Yangyang Gao; Fang Yuan; Fang Yu; Geoffrey M Thiele; Tatiana K Bronich; James R O'Dell; Dong Wang
Journal:  ACS Nano       Date:  2018-07-17       Impact factor: 15.881

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.